Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1985 1
1989 3
1990 3
1991 4
1992 3
1993 3
1994 2
1995 2
1996 4
1998 9
1999 1
2000 3
2001 3
2002 2
2003 1
2004 3
2005 2
2007 3
2008 6
2009 2
2010 1
2011 1
2015 1
2020 1
2021 4
2022 2
2023 2
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

69 results

Results by year

Filters applied: . Clear all
Page 1
Cutaneous pseudolymphomas.
Ploysangam T, Breneman DL, Mutasim DF. Ploysangam T, et al. Among authors: breneman dl. J Am Acad Dermatol. 1998 Jun;38(6 Pt 1):877-95; quiz 896-7. doi: 10.1016/s0190-9622(98)70154-9. J Am Acad Dermatol. 1998. PMID: 9631994 Review.
An uncommon presentation of cutaneous dissemination of gout.
Aggarwal P, Gorell ES, Flood KS, Spicknall K, Breneman D. Aggarwal P, et al. Among authors: breneman d. JAAD Case Rep. 2022 Oct 11;31:89-92. doi: 10.1016/j.jdcr.2022.09.027. eCollection 2023 Jan. JAAD Case Rep. 2022. PMID: 36545484 Free PMC article. No abstract available.
Evaluation of the cost and efficacy of home-formulated sunscreens.
Breneman A, Hancock J, Breneman C, Kadekaro AL, Breneman D. Breneman A, et al. Among authors: breneman d. J Am Acad Dermatol. 2021 May;84(5):1483-1485. doi: 10.1016/j.jaad.2020.07.067. Epub 2020 Jul 22. J Am Acad Dermatol. 2021. PMID: 32707259 No abstract available.
Ionizing radiation therapy in dermatology.
Goldschmidt H, Breneman JC, Breneman DL. Goldschmidt H, et al. Among authors: breneman dl. J Am Acad Dermatol. 1994 Feb;30(2 Pt 1):157-82; quiz 183-6. doi: 10.1016/s0190-9622(94)70014-1. J Am Acad Dermatol. 1994. PMID: 8288778 Review.
Lack of effect of benralizumab on signs and symptoms of moderate-to-severe atopic dermatitis: Results from the phase 2 randomized, double-blind, placebo-controlled HILLIER trial.
Guttman-Yassky E, Bahadori L, Brooks L, Clark KL, Grindebacke H, Ho CN, Katial R, Pham TH, Walton C, Datto CJ; HILLIER study group†. Guttman-Yassky E, et al. J Eur Acad Dermatol Venereol. 2023 Oct;37(10):e1211-e1214. doi: 10.1111/jdv.19195. Epub 2023 Jun 12. J Eur Acad Dermatol Venereol. 2023. PMID: 37178404 Clinical Trial. No abstract available.
Evaluation of cutaneous lymphomas.
Breneman DL. Breneman DL. Compr Ther. 1996 Mar;22(3):169-74. Compr Ther. 1996. PMID: 8706387 Review. No abstract available.
69 results